- Home
- RCUS vs ESTA Comparison
RCUS vs ESTA Comparison
Compare RCUS & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- ESTA
- Stock Information
- Founded
- RCUS 2015
- ESTA 2004
- Country
- RCUS United States
- ESTA Costa Rica
- Employees
- RCUS N/A
- ESTA N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- ESTA Industrial Specialties
- Sector
- RCUS Health Care
- ESTA Health Care
- Exchange
- RCUS Nasdaq
- ESTA Nasdaq
- Market Cap
- RCUS 1.4B
- ESTA 1.3B
- IPO Year
- RCUS 2018
- ESTA 2018
- Fundamental
- Price
- RCUS $13.81
- ESTA $33.15
- Analyst Decision
- RCUS Buy
- ESTA Buy
- Analyst Count
- RCUS 12
- ESTA 6
- Target Price
- RCUS $34.50
- ESTA $60.50
- AVG Volume (30 Days)
- RCUS 626.1K
- ESTA 591.2K
- Earning Date
- RCUS 02-19-2025
- ESTA 02-26-2025
- Dividend Yield
- RCUS N/A
- ESTA N/A
- EPS Growth
- RCUS N/A
- ESTA N/A
- EPS
- RCUS N/A
- ESTA N/A
- Revenue
- RCUS $263,000,000.00
- ESTA $153,071,000.00
- Revenue This Year
- RCUS $127.65
- ESTA $2.81
- Revenue Next Year
- RCUS N/A
- ESTA $23.95
- P/E Ratio
- RCUS N/A
- ESTA N/A
- Revenue Growth
- RCUS 119.17
- ESTA N/A
- 52 Week Low
- RCUS $13.51
- ESTA $30.20
- 52 Week High
- RCUS $20.31
- ESTA $60.12
- Technical
- Relative Strength Index (RSI)
- RCUS 33.05
- ESTA 28.00
- Support Level
- RCUS $13.51
- ESTA $30.20
- Resistance Level
- RCUS $15.62
- ESTA $47.71
- Average True Range (ATR)
- RCUS 0.60
- ESTA 2.79
- MACD
- RCUS -0.16
- ESTA -1.18
- Stochastic Oscillator
- RCUS 11.67
- ESTA 16.85
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.